Literature DB >> 18541616

Cerebral malaria in children is associated with long-term cognitive impairment.

Chandy C John1, Paul Bangirana, Justus Byarugaba, Robert O Opoka, Richard Idro, Anne M Jurek, Baolin Wu, Michael J Boivin.   

Abstract

OBJECTIVE: Cerebral malaria affects >785000 African children every year. We previously documented an increased frequency of cognitive impairment in children with cerebral malaria 6 months after their initial malaria episode. This study was conducted to determine the long-term effects of cerebral malaria on the cognitive function of these children.
METHODS: Children who were 5 to 12 years of age and presented to Mulago Hospital, Kampala, Uganda, with cerebral malaria (n = 44) or uncomplicated malaria (n = 54), along with healthy, asymptomatic community children (n = 89), were enrolled in a prospective cohort study of cognition. Cognitive testing was performed at enrollment and 2 years later. The primary outcome was presence of a deficit in >or=1 of 3 cognitive areas tested.
RESULTS: At 2-year follow-up testing, 26.3% of children with cerebral malaria and 12.5% with uncomplicated malaria had cognitive deficits in >or=1 area, as compared with 7.6% of community children. Deficits in children with cerebral malaria were primarily in the area of attention (cerebral malaria, 18.4%, vs community children, 2.5%). After adjustment for age, gender, nutrition, home environment, and school level, children with cerebral malaria had a 3.67-fold increased risk for a cognitive deficit compared with community children. Cognitive impairment at 2-year follow-up was associated with hyporeflexia on admission and neurologic deficits 3 months after discharge.
CONCLUSIONS: Cerebral malaria is associated with long-term cognitive impairments in 1 of 4 child survivors. Future studies should investigate the mechanisms involved so as to develop interventions aimed at prevention and rehabilitation.

Entities:  

Mesh:

Year:  2008        PMID: 18541616      PMCID: PMC2607241          DOI: 10.1542/peds.2007-3709

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  Increased brain activity in frontal and parietal cortex underlies the development of visuospatial working memory capacity during childhood.

Authors:  Torkel Klingberg; Hans Forssberg; Helena Westerberg
Journal:  J Cogn Neurosci       Date:  2002-01-01       Impact factor: 3.225

2.  The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples.

Authors:  B Y Sarfo; S Singh; J W Lillard; A Quarshie; R K Gyasi; H Armah; A A Adjei; P Jolly; J K Stiles
Journal:  Ann Trop Med Parasitol       Date:  2004-04

Review 3.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

Authors:  Sander Greenland
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

4.  Residual neurologic sequelae after childhood cerebral malaria.

Authors:  M B van Hensbroek; A Palmer; S Jaffar; G Schneider; D Kwiatkowski
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

5.  Early activation of microglia in the pathogenesis of fatal murine cerebral malaria.

Authors:  I M Medana; N H Hunt; T Chan-Ling
Journal:  Glia       Date:  1997-02       Impact factor: 7.452

6.  Cytokine profile suggesting that murine cerebral malaria is an encephalitis.

Authors:  V M Jennings; J K Actor; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 7.  Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review.

Authors:  Julie A Carter; Brian G R Neville; Charles R J C Newton
Journal:  Brain Res Brain Res Rev       Date:  2003-09

8.  Cognitive sequelae of severe malaria with impaired consciousness.

Authors:  P A Holding; J Stevenson; N Peshu; K Marsh
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Sep-Oct       Impact factor: 2.184

9.  Effects of early cerebral malaria on cognitive ability in Senegalese children.

Authors:  Michael J Boivin
Journal:  J Dev Behav Pediatr       Date:  2002-10       Impact factor: 2.225

10.  Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria.

Authors:  Chandy C John; Angela Panoskaltsis-Mortari; Robert O Opoka; Gregory S Park; Paul J Orchard; Anne M Jurek; Richard Idro; Justus Byarugaba; Michael J Boivin
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

View more
  143 in total

1.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

2.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  Evaluating Immunopathogenic Biomarkers During Severe Malaria Illness as Modifiers of the Neuropsychologic Benefits of Computer Cognitive Games Rehabilitation in Ugandan Children.

Authors:  Michael J Boivin; Alla Sikorskii; Noeline Nakasujja; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Robert O Opoka; Bruno Giordani
Journal:  Pediatr Infect Dis J       Date:  2019-08       Impact factor: 2.129

4.  Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results.

Authors:  Rachel Brim; Sebastian Mboma; Margaret Semrud-Clikeman; Sam Kampondeni; Jed Magen; Terrie Taylor; John Langfitt
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

Review 5.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

6.  Severe malarial anemia is associated with long-term neurocognitive impairment.

Authors:  Paul Bangirana; Robert O Opoka; Michael J Boivin; Richard Idro; James S Hodges; Regilda A Romero; Elsa Shapiro; Chandy C John
Journal:  Clin Infect Dis       Date:  2014-04-24       Impact factor: 9.079

7.  Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.

Authors:  Marcele F Bastos; Ana Carolina A V Kayano; João Luiz Silva-Filho; João Conrado K Dos-Santos; Carla Judice; Yara C Blanco; Nathaniel Shryock; Michelle K Sercundes; Luana S Ortolan; Carolina Francelin; Juliana A Leite; Rafaella Oliveira; Rosa M Elias; Niels O S Câmara; Stefanie C P Lopes; Letusa Albrecht; Alessandro S Farias; Cristina P Vicente; Claudio C Werneck; Selma Giorgio; Liana Verinaud; Sabrina Epiphanio; Claudio R F Marinho; Pritesh Lalwani; Rogerio Amino; Julio Aliberti; Fabio T M Costa
Journal:  FASEB J       Date:  2018-03-20       Impact factor: 5.191

Review 8.  Neurodevelopment: The Impact of Nutrition and Inflammation During Early to Middle Childhood in Low-Resource Settings.

Authors:  Chandy C John; Maureen M Black; Charles A Nelson
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

9.  Long-term Behavioral Problems in Children With Severe Malaria.

Authors:  John Mbaziira Ssenkusu; James Steven Hodges; Robert Opika Opoka; Richard Idro; Elsa Shapiro; Chandy Chiramukhathu John; Paul Bangirana
Journal:  Pediatrics       Date:  2016-10-05       Impact factor: 7.124

Review 10.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.